Spine Imaging
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Introduction to Neuroimaging
Introduction to Neuroimaging Aaron S. Field, MD, PhD Assistant Professor of Radiology Neuroradiology Section University of Wisconsin–Madison Updated 7/17/07 Neuroimaging Modalities Radiography (X-Ray) Magnetic Resonance (MR) Fluoroscopy (guided procedures) • MR Angiography/Venography (MRA/MRV) • Angiography • Diffusion and Diffusion Tensor • Diagnostic MR • Interventional • Perfusion MR • Myelography • MR Spectroscopy (MRS) Ultrasound (US) • Functional MR (fMRI) • Gray-Scale Nuclear Medicine ―Duplex‖ • Color Doppler • Single Photon Emission Computed Tomography (SPECT) Computed Tomography (CT) • Positron Emission Tomography • CT Angiography (CTA) (PET) • Perfusion CT • CT Myelography Radiography (X-Ray) Radiography (X-Ray) Primarily used for spine: • Trauma • Degenerative Dz • Post-op Fluoroscopy (Real-Time X-Ray) Fluoro-guided procedures: • Angiography • Myelography Fluoroscopy (Real-Time X-Ray) Fluoroscopy (Real-Time X-Ray) Digital Subtraction Angiography Fluoroscopy (Real-Time X-Ray) Digital Subtraction Angiography Digital Subtraction Angiography Indications: • Aneurysms, vascular malformations and fistulae • Vessel stenosis, thrombosis, dissection, pseudoaneurysm • Stenting, embolization, thrombolysis (mechanical and pharmacologic) Advantages: • Ability to intervene • Time-resolved blood flow dynamics (arterial, capillary, venous phases) • High spatial and temporal resolution Disadvantages: • Invasive, risk of vascular injury and stroke • Iodinated contrast and ionizing radiation Fluoroscopy (Real-Time X-Ray) Myelography Lumbar or -
Myelography in the Assessment of Degenerative Lumbar Scoliosis And
https://doi.org/10.14245/kjs.2017.14.4.133 KJS Print ISSN 1738-2262 On-line ISSN 2093-6729 CLINICAL ARTICLE Korean J Spine 14(4):133-138, 2017 www.e-kjs.org Myelography in the Assessment of Degenerative Lumbar Scoliosis and Its Influence on Surgical Management George McKay, Objective: Myelography has been shown to highlight foraminal and lateral recess stenosis more Peter Alexander Torrie, readily than computed tomography (CT) or magnetic resonance imaging (MRI). It also has the Wendy Bertram, advantage of providing dynamic assessment of stenosis in the loaded spine. The advent of weight-bearing MRI may go some way towards improving assessment of the loaded spine Priyan Landham, and is less invasive, however availability remains limited. This study evaluates the potential Stephen Morris, role of myelography and its impact upon surgical decision making. John Hutchinson, Methods: Of 270 patients undergoing myelography during 2006-2009, a period representing Roland Watura, peak utilisation of this imaging modality in our unit, we identified 21 patients with degenerative Ian Harding scoliosis who fulfilled our inclusion criteria. An operative plan was formulated by our senior author based initially on interpretation of an MRI scan. Subsequent myelogram and CT myelogram Department of Spinal Surgery, investigations were scrutinised, with any additional abnormalities noted and whether these im- Southmead Hospital, Bristol, United pacted upon the operative plan. Kingdom Results: From our 21 patients, 18 (85.7%) had myelographic findings not identified on MRI. Of Corresponding Author: note, in 4 patients, supine CT myelography yielded additional information when compared to George McKay supine MRI in the same patients. -
Study Guide Medical Terminology by Thea Liza Batan About the Author
Study Guide Medical Terminology By Thea Liza Batan About the Author Thea Liza Batan earned a Master of Science in Nursing Administration in 2007 from Xavier University in Cincinnati, Ohio. She has worked as a staff nurse, nurse instructor, and level department head. She currently works as a simulation coordinator and a free- lance writer specializing in nursing and healthcare. All terms mentioned in this text that are known to be trademarks or service marks have been appropriately capitalized. Use of a term in this text shouldn’t be regarded as affecting the validity of any trademark or service mark. Copyright © 2017 by Penn Foster, Inc. All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the copyright owner. Requests for permission to make copies of any part of the work should be mailed to Copyright Permissions, Penn Foster, 925 Oak Street, Scranton, Pennsylvania 18515. Printed in the United States of America CONTENTS INSTRUCTIONS 1 READING ASSIGNMENTS 3 LESSON 1: THE FUNDAMENTALS OF MEDICAL TERMINOLOGY 5 LESSON 2: DIAGNOSIS, INTERVENTION, AND HUMAN BODY TERMS 28 LESSON 3: MUSCULOSKELETAL, CIRCULATORY, AND RESPIRATORY SYSTEM TERMS 44 LESSON 4: DIGESTIVE, URINARY, AND REPRODUCTIVE SYSTEM TERMS 69 LESSON 5: INTEGUMENTARY, NERVOUS, AND ENDOCRINE S YSTEM TERMS 96 SELF-CHECK ANSWERS 134 © PENN FOSTER, INC. 2017 MEDICAL TERMINOLOGY PAGE III Contents INSTRUCTIONS INTRODUCTION Welcome to your course on medical terminology. You’re taking this course because you’re most likely interested in pursuing a health and science career, which entails proficiencyincommunicatingwithhealthcareprofessionalssuchasphysicians,nurses, or dentists. -
Pharmacologyonline 2: 727-753 (2010) Ewsletter Bradu and Rossini
Pharmacologyonline 2: 727-753 (2010) ewsletter Bradu and Rossini COTRAST AGETS - IODIATED PRODUCTS. SECOD WHO-ITA / ITA-OMS 2010 COTRIBUTIO O AGGREGATE WHO SYSTEM-ORGA CLASS DISORDERS AD/OR CLUSTERIG BASED O REPORTED ADVERSE REACTIOS/EVETS Dan Bradu and Luigi Rossini* Servizio Nazionale Collaborativo WHO-ITA / ITA-OMS, Università Politecnica delle Marche e Progetto di Farmacotossicovigilanza, Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona, Regione Marche, Italia Summary From the 2010 total basic adverse reactions and events collected as ADRs preferred names in the WHO-Uppsala Drug Monitoring Programme, subdivided in its first two twenty years periods as for the first seven iodinated products diagnostic contrast agents amidotrizoate, iodamide, iotalamate, iodoxamate, ioxaglate, iohexsol and iopamidol, their 30 WHO-system organ class disorders (SOCDs) aggregates had been compared. Their common maximum 97% levels identified six SOCDs only, apt to evaluate the most frequent single ADRs for each class, and their percentual normalization profiles for each product. The WILKS's chi square statistics for the related contingency tables, and Gabriel’s STP procedure applied to the extracted double data sets then produced profile binary clustering, as well as Euclidean confirmatory plots. They finally showed similar objectively evaluated autoclassificative trends of these products, which do not completely correspond to their actual ATC V08A A, B and C subdivision: while amidotrizoate and iotalamate, and respectively iohesol and iopamidol are confirmed to belong to the A and B subgroups, ioxaglate behaves fluctuating within A, B and C, but iodamide looks surprizingly, constantly positioned together with iodoxamate as binary/ternary C associated. In view of the recent work of Campillos et al (Science, 2008) which throws light on the subject, the above discrepancies do not appear anymore unexpected or alarming. -
Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1
TITLE 16. CRIMES AND OFFENSES CHAPTER 13. CONTROLLED SUBSTANCES ARTICLE 1. GENERAL PROVISIONS § 16-13-1. Drug related objects (a) As used in this Code section, the term: (1) "Controlled substance" shall have the same meaning as defined in Article 2 of this chapter, relating to controlled substances. For the purposes of this Code section, the term "controlled substance" shall include marijuana as defined by paragraph (16) of Code Section 16-13-21. (2) "Dangerous drug" shall have the same meaning as defined in Article 3 of this chapter, relating to dangerous drugs. (3) "Drug related object" means any machine, instrument, tool, equipment, contrivance, or device which an average person would reasonably conclude is intended to be used for one or more of the following purposes: (A) To introduce into the human body any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (B) To enhance the effect on the human body of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (C) To conceal any quantity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; or (D) To test the strength, effectiveness, or purity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state. (4) "Knowingly" means having general knowledge that a machine, instrument, tool, item of equipment, contrivance, or device is a drug related object or having reasonable grounds to believe that any such object is or may, to an average person, appear to be a drug related object. -
Treatment of Spinal Cord Vascular Malformations by Surgical Excision
J. Neurosurg. / Volume 30 / April, 1969 Treatment of Spinal Cord Vascular Malformations by Surgical Excision H. KRAYENBOHL, M. G. YA~ARGIL, M.D., AND H. G. McCLINTOCK* Section v] Neurosurgery, Kantonsspital, The University o] Ziirich, Ziirich, Switzerland ECENT developments have now made called attention to an increase in symptoms direct surgical attack the treatment during pregnancy with subsidence after of choice for spinal cord vascular delivery, z~ Newman has stated that he be- malformations. We are reporting 17 cases lieves the increase in symptoms in such cases treated with surgical excision, the last 11 of may be due to "venous congestion" from the which were operated on under the operating distended uterus and interestingly suggests microscope. the possibility of some "hormonal factor act- There is much confusion in the literature ing on the vessel walls. ''22 Although none of concerning the histological nomenclature our cases was a child, several authors have used to describe varieties of spinal vascular reported the occurrence in children and even malformations. This confusion is partly the in infants?, ~, 10,22,23 result of the lack of opportunity for ade- quate microscopic study of the entire lesion. Clinical Picture We prefer to follow the classification of History. The clinical history is usually one Bergstrand, et al.2 who divided these malfor- of three types. There can be 1) a slow mations into: 1) angioma cavernosum, 2) progression of neurological symptoms and angioma racemosum, and 3) angioreticu- signs, 2) progression followed with regres- loma. Some vascular malformations will sion or a stationary period, or 3) a sudden show characteristics of more than one group, apoplectic onset. -
2Nd Quarter 2001 Medicare Part a Bulletin
In This Issue... From the Intermediary Medical Director Medical Review Progressive Corrective Action ......................................................................... 3 General Information Medical Review Process Revision to Medical Record Requests ................................................ 5 General Coverage New CLIA Waived Tests ............................................................................................................. 8 Outpatient Hospital Services Correction to the Outpatient Services Fee Schedule ................................................................. 9 Skilled Nursing Facility Services Fee Schedule and Consolidated Billing for Skilled Nursing Facility (SNF) Services ............. 12 Fraud and Abuse Justice Recovers Record $1.5 Billion in Fraud Payments - Highest Ever for One Year Period ........................................................................................... 20 Bulletin Medical Policies Use of the American Medical Association’s (AMA’s) Current Procedural Terminology (CPT) Codes on Contractors’ Web Sites ................................................................................. 21 Outpatient Prospective Payment System January 2001 Update: Coding Information for Hospital Outpatient Prospective Payment System (OPPS) ......................................................................................................................... 93 he Medicare A Bulletin Providers Will Be Asked to Register Tshould be shared with all to Receive Medicare Bulletins and health care -
In-Vitro Cell Exposure Studies for the Assessment of Nanoparticle Toxicity in the Lung—A Dialog Between Aerosol Science and Biology$
Journal of Aerosol Science 42 (2011) 668–692 Contents lists available at ScienceDirect Journal of Aerosol Science journal homepage: www.elsevier.com/locate/jaerosci In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung—A dialog between aerosol science and biology$ Hanns-Rudolf Paur a, Flemming R. Cassee b, Justin Teeguarden c, Heinz Fissan d, Silvia Diabate e, Michaela Aufderheide f, Wolfgang G. Kreyling g, Otto Hanninen¨ h, Gerhard Kasper i, Michael Riediker j, Barbara Rothen-Rutishauser k, Otmar Schmid g,n a Institut fur¨ Technische Chemie (ITC-TAB), Karlsruher Institut fur¨ Technologie, Campus Nord, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany b Center for Environmental Health, National Institute for Public Health and the Environment, P.O. Box 1, 3720 MA Bilthoven, The Netherlands c Pacific Northwest National Laboratory, Fundamental and Computational Science Directorate, 902 Battelle Boulevard, Richland, WA 99352, USA d Institute of Energy and Environmental Technologies (IUTA), Duisburg, Germany e Institut fur¨ Toxikologie und Genetik, Karlsruher Institut fur¨ Technologie, Campus Nord, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany f Cultex Laboratories, Feodor-Lynen-Straße 21, 30625 Hannover, Germany g Comprehensive Pneumology Center, Institute of Lung Biology and Disease, Helmholtz Zentrum Munchen,¨ Ingolstadter¨ Landstrasse 1, 85764 Neuherberg, Germany h THL National Institute for Health and Welfare, PO Box 95, 70701 Kuopio, Finland i Institut fur¨ -
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01 -
Spinal Arachnoiditis Stephen I
THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCbS REVIEW ARTICLE: Spinal Arachnoiditis Stephen I. Esses and T.P. Morley SUMMARY: A review of the literature points to the many causes of arachnoiditis and the failure of treatment to arrest or reverse its effects. The true incidence cannot be determined, although it is probably lower than might at first appear from the published articles. In the radiological literature the diagnosis seems to derive from an examination of the films alone, often without reference to the clinical findings or appearance at operation. While attempts at treatment are usually unsuccessful, some iatrogenic cases can be prevented by the avoidance of intrathecal steroid injections or unduly rough or repeated surgical exploration of the lumbar vertebral canal. RESUME: Une revue de la litterature indique clairement que I'arachnoidite peut etre due a plusieurs causes et que son traitement est deficitaire. L'incidence reelle de I'arachnoidite ne peut etre determinee, mais elle est probablement inferieure au taux apparent selon les publications. Ainsi dans la litterature radiologique on semble etablir un diagnostic sur la base des films sans tenir compte des aspects clini- ques ou de la presentation chirurgicale. Quoique les essais therapeutiques soient generalement negatifs, on peut prevenir certaines causes iatrogeniques en evitant les injections intrathecals de steroides ou les explorations repetees, ou trop dures, du canal vertebral lombaire. Can. J. Neurol. Sci. 1983; 10:2-10 Feodor Krause (1907) was the first to describe adhesive dense collagen deposition which completely encases the lumbar arachnoiditis. By 1936 Elkington presented a com nerve roots. The roots are deprived of their blood supply plete analysis of forty-one cases under the tide "Meningitis and undergo progressive atrophy. -
Neuroradiology Back to the Future: Brain Imaging
Published December 8, 2011 as 10.3174/ajnr.A2936 50TH ANNIVERSARY PERSPECTIVES Neuroradiology Back to the Future: Brain Imaging E.G. Hoeffner SUMMARY: The beginning of neuroradiology can be traced to the early 1900s with the use of skull S.K. Mukherji radiographs. Ventriculography and pneumoencephalography were introduced in 1918 and 1919, re- spectively, and carotid angiography, in 1927. Technical advances were made in these procedures A. Srinivasan during the next 40 years that lead to improved diagnosis of intracranial pathology. Yet, they remained D.J. Quint invasive procedures that were often uncomfortable and associated with significant morbidity. The introduction of CT in 1971 revolutionized neuroradiology. Ventriculography and pneumoencephalogra- phy were rendered obsolete. The imaging revolution continued with the advent of MR imaging in the early 1980s. Noninvasive angiographic techniques have curtailed the use of conventional angiography, and physiologic imaging gives us a window into the function of the brain. In this historical review, we will trace the origin and evolution of the advances that have led to the quicker, less invasive diagnosis and resulted in more rapid therapy and improved outcomes. ABBREVIATIONS: CPA ϭ cerebellopontine angle; EDH ϭ epidural hematoma; LP ϭ lumbar punc- ture; NMR ϭ nuclear magnetic resonance; SDH ϭ subdural hematoma fforts to image the CNS began with skull radiographs duced by trauma, surgery, or infection.3 Skull radiographs Eshortly after Roentgen’s discovery of x-rays.1-3 In the early were also used to diagnose fractures and foreign bodies.9 20th century, contrast studies of the brain, by using air for Obtaining a single skull radiograph took minutes, with the contrast, were developed with the introduction of ventriculog- radiograph being produced on a glass plate with a slowly re- raphy and pneumoencephalography.4,5 Shortly thereafter, ce- sponding photographic emulsion. -
Clinical Utility of Arterial Spin-Labeling As a Confirmatory
CLINICAL REPORT BRAIN Clinical Utility of Arterial Spin-Labeling as a Confirmatory Test for Suspected Brain Death K.M. Kang, T.J. Yun, B.-W. Yoon, B.S. Jeon, S.H. Choi, J.-h. Kim, J.E. Kim, C.-H. Sohn, and M.H. Han ABSTRACT SUMMARY: Diagnosis of brain death is made on the basis of 3 essential findings: coma, absence of brain stem reflexes, and apnea. Although confirmatory tests are not mandatory in most situations, additional testing may be necessary to declare brain death in patients in whom results of specific components of clinical testing cannot be reliably evaluated. Recently, arterial spin-labeling has been incorpo- rated as part of MR imaging to evaluate cerebral perfusion. Advantages of arterial spin-labeling include being completely noninvasive and providing information about absolute CBF. We retrospectively reviewed arterial spin-labeling findings according to the following modified criteria based on previously established confirmatory tests to determine brain death: 1) extremely decreased perfusion in the whole brain, 2) bright vessel signal intensity around the entry of the carotid artery to the skull, 3) patent external carotid circulation, and 4) “hollow skull sign” in a series of 5 patients. Arterial spin-labeling findings satisfied the criteria for brain death in all patients. Arterial spin-labeling imaging has the potential to be a completely noninvasive confirmatory test to provide additional information to assist in the diagnosis of brain death. ABBREVIATION: ASL ϭ arterial spin-labeling rain death is defined as irreversible loss of brain and brain bioelectrical activity, electroencephalography is used in many Bstem function.